Business Context and Reporting Period
Company: Charles River Laboratories International, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 7, 2024
Reporting Period: Second quarter ended June 29, 2024
This filing serves as a notification that the company issued a press release on August 7, 2024, detailing its financial results for the second quarter. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references an attached press release for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no numerical values for these metrics can be extracted from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance compared to prior periods. It directs readers to the attached press release for such information.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing notes that the attached press release contains "forward-looking" statements protected by the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.
- Risks: The document states that risks relating to Charles River are set forth in other documents filed with the SEC, rather than listing them within this specific 8-K text.
- Unusual Items: No unusual items are described in the text of this filing.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release) for actual Q2 2024 financial figures (revenue, EPS, cash flow).
- Examine the "forward-looking statements" section in the press release for updated guidance and outlook.
- Consult the company's most recent 10-K or 10-Q filings for a comprehensive list of risk factors referenced in this report.
- Verify the specific date of the quarter end (June 29, 2024) when comparing to prior year periods.